Utility of myeloperoxidase stain in the diferential diagnosis of leukemia cutis vs. hystiocitoid sweet syndrome

Dermatology Online Journal

Volumn 17, Issue 4, 2011, Pages

  Valerón Almazán, Pedro ^a   Bastida, Jesús ^a   Vilar, Jaime ^a   Santana, Néstor ^a   Medina, Carolina ^a   Carretero, Gregorio ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYTARABINE; HEMOGLOBIN; IDARUBICIN; MYELOPEROXIDASE; ANTINEOPLASTIC AGENT; PEROXIDASE; TUMOR MARKER;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AGED; ARTICLE; BACK; BLAST CELL; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ERYTHEMA; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYSTIOCITOID SWEET SYNDROME; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LEUKEMIA CELL; MALE; MYELOID LEUKEMIA CUTIS; MYELOPEROXIDASE STAINING; NUCLEAR SHAPE; SKIN BIOPSY; SKIN INFILTRATE; STAINING; ACUTE GRANULOCYTIC LEUKEMIA; CANCER INVASION; ENZYMOLOGY; LETTER; METHODOLOGY; PATHOLOGY; SKIN; SKIN TUMOR; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IDARUBICIN; LEUKEMIA, MYELOID, ACUTE; LEUKEMIC INFILTRATION; MALE; PEROXIDASE; SKIN; SKIN NEOPLASMS; STAINING AND LABELING; SWEET SYNDROME; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79960713679     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Su WP, Buechner SA, Li CY. Clinicopathologic correlations in leucemia cutis. J Am Acad Dermatol. 1984;11(1):121-8. [PubMed]
2. Sepp N, Radaskiewicz T, Meiger CJ, Smolle J, Seewan H, Fritsch P, Kerl H. Specific skin manifestations in acute leukemia with monocytic differentiation. A morphologic and inmunohistochemical study of 11 cases. Cancer. 1993;71(1):124-32. [PubMed]
3. Baer MR, Barcos M, Farrell H, Raza A, Preisler HD. Acute myelogenous leucemia with leucemia cutis. Eighteen cases between 1969 and 1986. Cancer. 1989;63(11):2192-200.[PubMed]
4. Desch JK, Smoller BR. The spectrum of cutaneous disease in leukemias. J Cutan Pathol. 1993;20(5):407-10. [PubMed]
5. Ratnam KV, Khor CJ, Su WP. Leukemia Cutis. Dermatol Clin. 1994;12(2):419-431.[PubMed]
6. Requena L, Kutzner H, Palmedo G, Pascual M, Fernández-Herrera J, Fraga J, García-Díez A, Sanchez-Yus E. Histiocytoid Sweet Syndrome: a dermal infiltration of inmature neutrophilic granulocytes. Arch Dermatol. 2005;141(7):834-42. [PubMed]
7. Chow S, Pasternak S, Green P, Tremaine R, Reardon M, Murray S, Northgrave S, Walsh N. Histiocytoid neutrophilic dermatoses and panniculitides: variations on a theme. Am J Dermatopathol. 2007;29(4):334-41. [PubMed]
8. Cronin DM, George TI, Sundram UN. An updated approach to the diagnosis of myeloid Leukemia cutis. Am J Clin Pathol. 2009;132(1):101-10. [PubMed]
9. Cibull TL, Thomas AB, O'Malley DP, Billings SD. Myeloid leukemia cutis: a histologic and immunohistochemical review. J Cutan Pathol. 2008;35(2):180-5. [PubMed]
10. Vignon-Pennamen MD, Aractingi S. Sweet's syndrome and leukemia cutis: a common skin homing mechanism?. Dermatology. 2003;206(2):81-4. [PubMed]
11. Deguchi M, Tsunoda T, Yuda F, Tagami H. Sweet's syndrome in acute myelogenous leukemia showing dermal infiltration on leukemic cells. Dermatology. 1997;194(2):182-4. [PubMed]
12. Urano Y, Miyaoka Y, Kosaka M, Kabe K, Uchida N, Arase S. Sweet's syndrome associated with chronic myelogenous leukemia: demonstration of leukemic cells within a skin lesion. J Am Acad Dermatol. 1999;40(2 Pt 1):275-9. [PubMed]
13. Dominguez ER, Greene JN, Sandin RL, DeGregorio R, Glass LF. Sweet syndrome and leukemia cutis in the same patient: a case report and review. Cancer Control. 1995;2(4):343-6. [PubMed]
14. del Pozo J, Martínez W, Pazos JM, Yebra-Pimentel MT, García-Silva J, Fonseca E. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders. Int J Dermatol. 2005;44(8):677-80. [PubMed]